Amit Mitra

14PUBLICATIONS

91CO-AUTHORS

Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 12, 2026

Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance.

|Mar 12, 2026

Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma.

Jeremiah Pfitzer, Sayak Chakravarti, Suman Mazumder

|Nov 27, 2025

Clofazimine Treatment Modulates Key Non-Coding RNAs Associated with Tumor Progression and Drug Resistance in Lethal Prostate Cancer.

Sarah Batten, Harish Kumar, Jeremiah Pfitzer

|Dec 19, 2024

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Jeremy B Foote, Tyler E Mattox, Adam B Keeton

|Oct 14, 2024

Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).

Hongwei Tang, Huihuang Yan, Suganti Shivaram

|Dec 06, 2023

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.

Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder

Pageof 3

Frequent Collaborators

Shaji Kumar

Robert D Arnold

Neeraj Sharma

Brian Van Ness

Ujjal Kumar Mukherjee

3 joint publications

Linda B Baughn

3 joint publications

Panagiotis Mistriotis

2 joint publications

Gang Zhou

2 joint publications

Gary A Piazza

2 joint publications

Clayton Yates

Frequent Collaborators

Shaji Kumar

Robert D Arnold

Neeraj Sharma

Brian Van Ness